Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jan;77(1):12-22.
doi: 10.1053/j.ajkd.2020.06.014. Epub 2020 Aug 13.

Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial

Nisha Bansal  1 , David V Glidden  2 , Rajnish Mehrotra  2 , Raymond R Townsend  3 , Jordana Cohen  3 , Lori Linke  4 , Farshad Palad  5 , Hannah Larson  4 , Chi-Yuan Hsu  5
Affiliations
Randomized Controlled Trial

Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial

Nisha Bansal et al. Am J Kidney Dis. 2021 Jan.

Abstract

Rationale & objective: Observational studies have reported a U-shaped association between blood pressure (BP) before a hemodialysis session and death. In contrast, because a linear association between out-of-dialysis-unit BP and death has been reported, home BP may be a better target for treatment. To test the feasibility of this approach, we conducted a pilot trial of treating home versus predialysis BP in hemodialysis patients.

Study design: A 4-month, parallel, randomized, controlled trial.

Settings & participants: 50 prevalent hemodialysis patients in San Francisco and Seattle. Participants were randomly assigned using 1:1 block randomization, stratified by site.

Interventions: To target home systolic BP (SBP) of 100-<140 mm Hg versus predialysis SBP of 100-<140mm Hg. Home and predialysis SBPs were ascertained every 2 weeks. Dry weight and BP medications were adjusted to reach the target SBP.

Outcomes: Primary outcomes were feasibility, adherence, safety. and tolerability.

Results: 50 of 70 (71%) patients who were approached agreed to participate. All enrollees completed the study except for 1 who received a kidney transplant. In the home BP treatment group, adherence to obtaining/reporting home BP was 97.4% (and consistent over the 4 months). There was no increased frequency of high (defined as SBP>200mm Hg; 0.2% vs 0%) or low (defined as<90mm Hg; 1.8% vs 1.2%) predialysis BP readings in the home versus predialysis treatment arms, respectively. However, participants in the home BP arm had higher frequency of fatigue (32% vs 16%).

Limitations: Small sample size.

Conclusions: This pilot trial demonstrates feasibility and high adherence to home BP measurement and treatment in hemodialysis patients. Larger trials to test the long-term feasibility, efficacy, and safety of home BP treatment in hemodialysis patients should be conducted.

Funders: National Institutes of Health, Satellite Healthcare, and Northwest Kidney Centers.

Trial registration: Registered at ClinicalTrials.gov with study number NCT03459807.

Keywords: BP management; BP target; Blood pressure (BP); clinical trial; dry weight adjustment; end-stage renal disease (ESRD); hemodialysis; home BP; hypertension; masked hypertension; pilot study; pragmatic trial; white coat effect.

PubMed Disclaimer

Conflict of interest statement

Peer Review: Received December 16, 2019. Evaluated by 2 external peer reviewers, with direct editorial input from a Statistics/Methods Editor and an International Editor, who served as Acting Editor-in-Chief. Accepted in revised form June 11, 2020. The involvement of an Acting Editor-in-Chief was to comply with AJKD’s procedures for potential conflicts of interest for editors, described in the Information for Authors & Journal Policies.

Figures

Figure 1.
Figure 1.
Flow diagram of trial participants. Abbreviations: EMR, electronic medical record; SBP, systolic blood pressure.
Figure 2.
Figure 2.
Mean predialysis systolic blood pressures (SBPs) over 4 months among participants randomly assigned to the home SBP versus dialysis SBP treatment groups (N = 50). Error bars represent standard deviation.
Figure 3.
Figure 3.
Mean home and predialysis systolic blood pressures (SBPs) over 4 months among participants randomly assigned to the home BP treatment group (n = 25). Error bars represent standard deviation.
See this image and copyright information in PMC

Comment in

References

    1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Collaboration PS. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349): 1903–1913. - PubMed
    1. Flack JM, Neaton J, Grimm R Jr., et al. Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation. 1995;92(9): 2437–2445. - PubMed
    1. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335(8692): 765–774. - PubMed
    1. Vamos EP, Harris M, Millett C, et al. Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study. BMJ (Clinical research ed.). 2012;345: e5567. - PMC - PubMed
    1. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension (Dallas, Tex. : 1979). 2003;42(5): 1050–1065. - PubMed

Publication types

MeSH terms

Substances

Associated data